MUDr. Viera Sandecká, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
phone: | +420 532 23 3881, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 103
2022
-
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data
Neoplasma, year: 2022, volume: 69, edition: 6, DOI
-
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
Biomedicines, year: 2022, volume: 10, edition: 10, DOI
-
Waldenströmova makroglobulinemie, klinické příznaky, přehled léčebných možností a vlastní zkušenosti s léčbou ibrutinibem
Onkologie, year: 2022, volume: 16, edition: Supplementum B, DOI
2021
-
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data
European Journal of Haematology, year: 2021, volume: 107, edition: 4, DOI
-
Léčba tří pacientů s Erdheimovou-Chesterovou chorobou kladribinem, případně kombinací kladribinu a cyklofosfamidu a přehled léčby této nemoci
Vnitřní lékařství, year: 2021, volume: 67, edition: 3, DOI
-
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience
Annals of hematology, year: 2021, volume: 100, edition: 10, DOI
-
Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant
Neoplasma, year: 2021, volume: 68, edition: 3, DOI
-
Transformace IgM-MGUS do Waldenströmovy makroglobulinemie u 2 z 6 pacientů v průběhu léčby syndromu Schnitzlerové
Vnitřní lékařství, year: 2021, volume: 67, edition: 3, DOI
2020
-
Co je Gaucherova nemoc?
Year: 2020, type:
-
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience
Neoplasma, year: 2020, volume: 67, edition: 4, DOI